A First‐In‐Human, Randomized, Placebo‐Controlled Single and Multiple Ascending Dose Study of Izicopan (INF904), A Second‐Generation Oral Small Molecule C5a Receptor Inhibitor, in Healthy Participants
Joseph F. Grippo,
Anja Pfaff,
Zhongli Xu,
Isabell Otto,
Claus Thielert,
Mihaly Imre,
Rui Liu,
Wantanee Phuapradit,
Yazhong Pei,
Cuie Chen,
Maria Habel,
Renfeng Guo,
Camilla Chong Clinical Pharmacology in Drug Development
· Wiley
· 2026-11-02
· DOI: 10.1002/cpdd.70123
Аннотация
Clinical Pharmacology in Drug Development, Volume 15, Issue 11, November 2026.
Joseph F. Grippo, Anja Pfaff, Zhongli Xu, Isabell Otto, Claus Thielert, Mihaly Imre et al. A First‐In‐Human, Randomized, Placebo‐Controlled Single and Multiple Ascending Dose Study of Izicopan (INF904), A Second‐Generation Oral Small Molecule C5a Receptor Inhibitor, in Healthy Participants. // Clinical Pharmacology in Drug Development. – 2026. – DOI: 10.1002/cpdd.70123. – URL: https://accp1.onlinelibrary.wiley.com/doi/10.1002/cpdd.70123?af=R
Joseph F. Grippo, Anja Pfaff, Zhongli Xu, Isabell Otto, Claus Thielert, Mihaly Imre, Rui Liu, Wantanee Phuapradit, Yazhong Pei, Cuie Chen, Maria Habel, Renfeng Guo, & Camilla Chong (2026). A First‐In‐Human, Randomized, Placebo‐Controlled Single and Multiple Ascending Dose Study of Izicopan (INF904), A Second‐Generation Oral Small Molecule C5a Receptor Inhibitor, in Healthy Participants. Clinical Pharmacology in Drug Development. https://doi.org/10.1002/cpdd.70123
Joseph F. Grippo, et al. “A First‐In‐Human, Randomized, Placebo‐Controlled Single and Multiple Ascending Dose Study of Izicopan (INF904), A Second‐Generation Oral Small Molecule C5a Receptor Inhibitor, in Healthy Participants.” Clinical Pharmacology in Drug Development, 2026. doi:10.1002/cpdd.70123.
@article{Grippo2026,
title = {A First‐In‐Human, Randomized, Placebo‐Controlled Single and Multiple Ascending Dose Study of Izicopan (INF904), A Second‐Generation Oral Small Molecule C5a Receptor Inhibitor, in Healthy Participants},
author = {Grippo, Joseph F. and Pfaff, Anja and Xu, Zhongli and Otto, Isabell and Thielert, Claus and Imre, Mihaly and Liu, Rui and Phuapradit, Wantanee and Pei, Yazhong and Chen, Cuie and Habel, Maria and Guo, Renfeng and Chong, Camilla},
journal = {Clinical Pharmacology in Drug Development},
year = {2026},
doi = {10.1002/cpdd.70123},
url = {https://accp1.onlinelibrary.wiley.com/doi/10.1002/cpdd.70123?af=R}
}